mTOR ATP-competitive inhibitor INK128 inhibits neuroblastoma growth via blocking mTORC signaling
Huiyuan Zhang(Chengdu University of Technology), Jianhua Yang(Children's National), Shan Guan(Army Medical University), Songbin Fu(Shihezi University), Yihui Fan(Nantong University), Jed G. Nuchtern(Baylor College of Medicine), Roma H. Patel(Michael E. DeBakey VA Medical Center), Jun Dou(Qingdao University), Peter E. Zage(Moores Cancer Center), Zhenghu Chen(Yangtze River Pharmaceutical Group (China)), Sanjeev A. Vasudevan(Baylor College of Medicine), Eugene S. Kim(Cedars-Sinai Medical Center), Yang Yu(Harbin Medical University), Hong Zhang(The University of Texas MD Anderson Cancer Center), Wei Liu(Academy of Military Medical Sciences), Yanling Zhao(Baylor College of Medicine), Yan Shi(Guangdong Academy of Medical Sciences), Jin Cheng(Sun Yat-sen University), Xin Xu(Baylor College of Medicine)
Cited by 49
Related Papers
NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer
|Protein & Cell|2013|767
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension
|New England Journal of Medicine|2021|742
Etiological and epidemiological features of acute respiratory infections in China
|Nature Communications|2021|530